Search for Clinical Trial Results
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - 25 Studies Found
Status | Study |
Completed |
Study Name: Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma Condition: Acute T-Cell Leukemia-Lymphoma Date: 2003-05-20 Interventions: Biological: Alemtuzumab Infusion of Campath-1H 3 mg on day # 1, 10 mg on day #2, and 30 mg day # 3 follo |
Completed |
Study Name: Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia Condition: Leukemia Date: 2012-04-19 Interventions:
|
Completed |
Study Name: DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia Condition: Leukemia Date: 2009-05-09 Interventions:
|
Completed |
Study Name: Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia Condition: Leukemia Date: 2012-06-20 Interventions:
|
Completed |
Study Name: Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia Condition: Leukemia Date: 2011-02-11 Interventions:
|
Terminated |
Study Name: A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013) Condition:
Date: 2005-09-12 Interventions:
|
Terminated |
Study Name: Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens Condition:
Date: 2007-01-05 Interventions:
|
Completed |
Study Name: 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Condition:
Date: 1999-11-01 Interventions: Drug: nelarabine |
Recruiting |
Study Name: Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma Condition:
|